Yukinori Okada

University of Tokyo
Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (17)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Identifying the causal variants and mechanisms that drive complex traits and diseases remains a core problem in human genetics 1–5 . Most of these variants individually have weak effects 6 and lie in non-coding gene-regulatory elements 7–10 , for which we lack a complete understanding of how single-nucleotide alterations modulate transcriptional processes to affect human phenotypes 5,11–15 . To address this problem, we measured the activity of 221,412 fine-mapped trait-associated variants using a massively parallel reporter assay 16–20 in 5 diverse cell types. We show that this assay effectively discriminates between likely causal variants and controls, and identified 13,121 regulatory variants with high precision. Although the effects of these variants largely agree with orthogonal measures of function, only 69% of them can plausibly be explained by the disruption of a known transcription factor binding motif. We investigated the mechanisms of 136 variants using saturation mutagenesis and assigned affected transcription factors for 91% of variants without a clear canonical mechanism. Finally, we detected regulatory epistasis at 11% of tested regulatory variants in close proximity and identified multiple functional variants on the same haplotype at a small, but important, subset of trait-associated loci. Overall, our study provides a systematic functional characterization of likely causal common variants that underlie complex and molecular human traits, enabling new insights into the regulatory grammar underlying disease risk.

Year:

2026

Background Sex hormone alterations, such as estrogen deficiency or testosterone excess, substantially increase cardiovascular disease (CVD) risk in females. Dietary fibre and its microbial by-products, short-chain fatty acids (SCFAs), have cardioprotective effects, but it remains unclear whether these benefits extend to females with an altered sex hormone profile. In this study, we aim to investigate whether dietary fibre intake, measured via plasma acetate—the most abundant SCFA—is associated with improved cardiovascular outcomes in females with altered sex hormone profiles. Methods This cohort study included 116,235 female participants from the UK Biobank and Biobank Japan with up to 10 years of follow-up. We analysed early menopause (as a surrogate for estrogen insufficiency) and plasma free testosterone (in a subset). The primary outcome was major adverse cardiovascular events (MACE). Secondary outcomes were blood pressure. Proteomics analyses explored potential mechanisms. Results Acetate levels were associated with lower 10-year MACE incidence (-0.618/1000 woman-year, HR=0.900, p=0.002) and systolic blood pressure (-0.231 mmHg per 1 SD, p <0.001) in the UK Biobank. High acetate levels attenuated the increased MACE risk associated with early menopause (HR=1.158, p =0.057) compared with low acetate (HR=1.425, p <0.001), with similar patterns replicated in Biobank Japan (high: HR=1.322, p =0.090; low: HR=1.385, p =0.042). Proteomics analyses suggested a mechanism involving pro-inflammatory proteins. Moreover, high acetate levels attenuated the increased MACE associated with elevated free testosterone in the UK Biobank (high: HR=1.238, p =0.024; low: HR=1.056, p =0.666). A significant interaction between acetate and free testosterone on systolic blood pressure indicated that the effect of rising testosterone on blunting acetate’s effect (β=0.167, 95% CI: [5.212×10⁻ 2 −2.818×10⁻ 1 ], p =0.004) was partially mediated by central obesity (waist-to-hip ratio). Conclusions Higher plasma acetate levels were associated with lower cardiovascular risk, particularly in females with early menopause or elevated free testosterone, potentially via inflammatory pathways. These findings underscore the importance of hormonal context in shaping cardiometabolic resilience and support personalised CVD prevention strategies for females with altered sex hormone profiles, including increasing dietary fibre intake.

Year:

2026

Many non-coding variants influence complex traits and diseases through gene regulation, yet the mechanisms linking these variants to downstream biology remain poorly understood. Here, we present eQTLGen Phase 2 , a comprehensive genome-wide analysis of gene expression quantitative trait loci (eQTLs) in 43,301 blood samples from 52 datasets. Beyond local cis -effects, this sample size enabled the first systematic mapping of trans -eQTLs at scale. We identify cis -eQTLs for nearly all expressed genes (94.7%) and trans -eQTLs for over half (56.2%). Second, by colocalizing cis -eQTLs with trans -eQTLs, we infer a directed gene regulatory network comprising 47,554 directed gene regulatory relationships. These networks reveal how genetic perturbations in upstream regulators produce dose-dependent downstream effects, supported by Perturb-seq and ChIP-seq data. Third, integrating this network with 87 genome-wide association studies allows us to systematically prioritize trait-relevant pathways and candidate genes. Variants exerting both cis – and trans -effects are markedly more likely to colocalize with trait associations than cis -only variants, delineating a subset of functionally active cis -eQTLs from a large group with limited downstream impact. This distinction provides a conceptual framework for identifying regulatory variants that truly mediate complex trait biology. Together, these results provide a publicly available resource of cis – and trans -eQTLs and an in vivo scaffold for human gene-regulatory networks, elucidating how propagation of cis -effects modulates complex disease.

Year:

2026

We report the findings of a genome-wide association study (GWAS) meta-analysis of endometriosis across 14 biobanks worldwide, including 32% non-European patient participants, as part of ​the ​Global Biobank Meta-Analys​i​s Initiative​ (GBMI)​. Out of 58 total loci (29 previously unreported), the largest meta-analysis accounted for 46 (20 previously unreported). We detected the first genome-wide significant loci (2p13.3 and 20q13.2) uniquely driven by the African-ancestry meta-analysis. Our imaging- and surgery-confirmed phenotypes yielded six additional previously unreported loci. Leveraging our large and diverse study population, we observed SNP heritability estimates of 9-13% for all ancestry groups, and 13 loci had at least one variant in the credible set after fine-mapping. Investigating the complex array of endometriosis comorbidities and risk factors revealed 135 genetically correlated phenotypes and 95 with evidence of vertical pleiotropy, including triglycerides and anxiety disorders. We prioritized 35 disease-relevant cellular contexts from the endometrial cell atlas and found 322 examples of differentially expressed genes in cells from donors with endometriosis. Further high-throughput multi-omic analyses implicated a total of 282 genes in endometriosis pathogenesis. Our diverse, comprehensive GWASs, with downstream analyses spanning molecular to phenotypic scales, provide detailed evidence for aspects of endometriosis including the role of immune cell types, Wnt signaling, and cellular proliferation. These interconnected pathways and risk factors underscore the complex, multi-faceted etiology of endometriosis, suggesting multiple targets for precise and effective therapeutic interventions.

Year:

2025

Centromeres are among the most diverse and dynamically evolving regions of the human genome and are commonly affected in various human cancers. However, organized into highly repetitive α-satellite higher-order repeats (HORs), human centromere sequences have long resisted detailed genomic analysis. Although the development of long-read sequencing platforms has enabled the analysis of complete centromere sequences, their application to a large set of samples is still largely limited, preventing our understanding of centromere variation and haplotype structures across large human populations and the structural basis of centromere-involving translocations in cancer. Here we show that rare k-mers present in centromeric regions can serve as effective markers for dissecting the complexity of centromere structure, particularly that of active α-satellite HOR arrays (aHOR arrays), across human populations and for understanding centromere-involving abnormalities in cancer. Based on rare k-mer-based clustering, centromere aHOR arrays are clustered into discrete haplogroups (aHOR-HGs) with distinct structural features. These k-mers were also used to develop a framework that enables the inference of haplogroups in a given sample based on short-read whole genome sequencing (WGS) data (ascairn). By applying ascairn to large-scale human population datasets ( n > 3,300), we revealed the diversity of aHOR-HGs and their geographic histories across populations. The rare k-mer-based approach was also applied to investigate the structure of 1p/19q co-deletion, a highly recurrent centromere-involving translocation in IDH -mutated oligodendrogliomas. Analyzing short-read WGS data from 142 cases with 1p/19q co-deletion using rare k-mers, we showed that breakpoints of 1p/19q co-deletion were mapped to aHOR arrays in chromosomes 1 ( D1Z7 ) and 19 ( D19Z3 ), which was validated by long-read sequencing of two 1p/19q co-deletion-positive cases. Notably, the translocation preferentially involved haplogroups composed of haplotypes containing larger regions susceptible to rearrangement. These results highlight the role of rare k-mers in dissecting the complexity of centromere sequences and their evolutionary history as well as understanding centromere-involving abnormalities associated with human diseases.

Year:

2025

Oculopharyngodistal myopathy (OPDM) is caused by CGG triplet repeat expansions in six genes. To explore the genetics and epigenetics of OPDM, we conducted CRISPR/Cas9-targeted resequencing of repeat regions in 89 patients. Repeat regions essentially comprised pure CGG expansions, but exhibited size variability, even within patients. Expanded LRP12 and GIPC1 alleles showed distinct single nucleotide variant patterns, suggesting founder haplotypes. LRP12 -expanded reads lacked flanking sequences present in non-expanded reads, whereas GIPC1 expanded repeats contained specific nucleotide patterns in their 5’-regions. Structural variations were identified in some patients. A significant inverse correlation was observed between repeat length and age at onset in patients with GIPC1 or NOTCH2NLC expansions, while this was disturbed by higher methylation of expanded regions in patients with LRP12 expansions, leading to delayed onset. These findings reveal a complex interplay among repeat size, sequence context, and epigenetic state in OPDM pathogenesis, advancing knowledge and providing opportunities for therapeutic intervention.

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Collaborators (103)

Kyuto Sonehara

Associate Professor

University of Tsukuba

JAPAN
View details

Qingbo Wang

Associate Professor

University of Tokyo

JAPAN
View details

Annique Claringbould

Assistant Professor

Erasmus MC

NETHERLANDS
View details

Marie Loh

Assistant Professor

Lee Kong Chian School of Medicine

SINGAPORE
View details

Claire Palles

Associate Professor

University of Birmingham

UNITED KINGDOM
View details

Javier Martin

Professor

Instituto de Parasitología y Biomedicina López-Neyra

SPAIN
View details

Katie Burnham

University of Oxford

UNITED KINGDOM
View details

Sini Nagpal

Assistant Professor

Indian Institute of Technology, Bombay

View details

Brenda WJH Penninx

Professor

-

NETHERLANDS
View details

Yotaro Ochi

Kyoto University

JAPAN
View details

René Pool

University of Amsterdam

NETHERLANDS
View details

Markus Scholz

Leipzig University

GERMANY
View details

Ines Gockel

University Hospital Leipzig

GERMANY
View details

Johannes Schumacher

Philipps-Universität Marburg

GERMANY
View details

Farzana Jasmine

Staff Scientist

University of Chicago

UNITED STATES
View details

Sergio E Baranzini

Professor

University of California

UNITED STATES
View details

Yoshitaka Isaka

Osaka University Graduate School of Medicine

JAPAN
View details

Tsubasa Miyauchi

Keio University Hospital

JAPAN
View details

Marta Eugenia Alarcón Riquelme

Scientific Director

Centro Pfizer - Universidad de Granada - Junta de Andalucía de Genómica e Investigación Oncológica

SPAIN
View details

Laura Raffield

Assistant Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

Dirk Paul

Interim Head of PMB BioPharma

AstraZeneca UK Limited

UNITED KINGDOM
View details

Axel Hillmer

Assoc. Prof

University Hospital Bonn

GERMANY
View details

Puya Gharahkhani

Team Head, Associate Professor

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

Taro Tsujimura

Lecturer

Kyoto University

JAPAN
View details

Yuan Luo

Chief AI Officer and Associate Professor

Northwestern University

UNITED STATES
View details

Digna R. Velez Edwards

Vanderbilt University Medical Center

UNITED STATES
View details

Seiya Imoto

University of Tokyo

JAPAN
View details

Masayuki Nishide

Osaka University

JAPAN
View details

Hideyuki Okano

Dean and Professor

Keio University School of Medicine

JAPAN
View details

Yuji Yamamoto

Osaka University Graduate School of Medicine

JAPAN
View details

Erik Garrison

Associate Professor

University of Tennessee Health Science Center

UNITED STATES
View details

Jouke-Jan Hottenga

Senior Researcher

Hamad Bin Khalifa University

QATAR
View details

Roel A. Ophoff

Professor

University of California, Los Angeles

UNITED STATES
View details

Seishi Ogawa

Kyoto University

JAPAN
View details

Atsushi Kumanogoh

Professor

Osaka University Graduate School of Medicine

JAPAN
View details

Ana Viñuela

Academic, Lecturer (Teaching and Research)

University of Dundee

UNITED KINGDOM
View details

Pashupati Mishra

Tampere University

FINLAND
View details

Emma Elisabeth Davenport

Group Leader

Wellcome Sanger Institute

UNITED KINGDOM
View details

Lisa Moran

Dietitian

MONASH UNIVERSITY

AUSTRALIA
View details

José Manuel Soria Fernández

Principal Investigator. Head of Group

Hospital de la Santa Creu i Sant Pau

SPAIN
View details

Ian Tomlinson

University of Edinburgh

UNITED KINGDOM
View details

Julian Knight

University of Oxford

UNITED KINGDOM
View details

Mika Kähönen

University of Tampere

FINLAND
View details

Muhammad Kibriya

Research Associate Professor

University of Chicago

UNITED STATES
View details

Alexander Teumer

Professor

University Medicine Greifswald

GERMANY
View details

Keisuke Kataoka

Chief

National Cancer Center Research Institute

JAPAN
View details

Alan Sanders

Clinical Associate Professor of Psychiatry

NorthShore University HealthSystem

UNITED STATES
View details

Francine Z Marques

MONASH UNIVERSITY

AUSTRALIA
View details

Andrew Brown

Principal Investigator

University of Dundee

UNITED KINGDOM
View details

Carlo Maj

Head of Bioinformatics | Research Group Leader – Genetic Epidemiology

University of Marburg

GERMANY
View details

Chaoran Yang

Monash University Malaysia.

AUSTRALIA
View details

Toni Boltz

Massachusetts General Hospital

UNITED STATES
View details

Akiyoshi Nakayama

Professor

National Defense Medical College

JAPAN
View details

Quinn Ostrom

Assistant Professor

Duke University School of Medicine

UNITED STATES
View details

Zoltán Kutalik

Full Professor

University of Lausanne

SWITZERLAND
View details

Soumya Raychaudhuri

Harvard University

UNITED STATES
View details

Caleb Lareau

Assistant Member

Memorial Sloan Kettering Cancer Center

UNITED STATES
View details

David Whiteman

Deputy Director

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

Beatrice Melin

Professor

Umea University

SWEDEN
View details

Katja Pahkala

Associate professor, Academy research fellow

University of Turku

FINLAND
View details

Emma Raitoharju

Senior Researcher

University of Tampere

FINLAND
View details

Stuart MacGregor

Professor

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

Yasunori Kogure

Senior Researcher

National Cancer Center Research Institute

JAPAN
View details

Dominik Heider

Diretor

University of Münster

GERMANY
View details

Jonathan Shortt

Assistant Research Professor

University of Colorado Anschutz Medical Campus

UNITED STATES
View details

Grant Montgomery

Professorial Research Fellow

University of Queensland

AUSTRALIA
View details

Annette Peters

Chair of Epidemiology

Ludwig-Maximilians-Universität München

GERMANY
View details

Kaur Alasoo

Associate Professor

University of Tartu

ESTONIA
View details

Motohiro Kato

-

JAPAN
View details

Fumitaka Inoue

Associate Professor

Kyoto University

JAPAN
View details

Joachim Thiery

Dean of Medicine and UKSH Board for Research snd Education

Kiel University

GERMANY
View details

Glennis Logsdon

Assistant Professor

University of Pennsylvania

UNITED STATES
View details

Alexis Battle

Professor

Johns Hopkins University

UNITED STATES
View details

Ichizo Nishino

Director

-

JAPAN
View details

Holger Kirsten

Leipzig University

GERMANY
View details

Olli T. Raitakari

University of Turku

FINLAND
View details

Alexander Gusev

Associate Professor

Dana-Farber Cancer Institute

UNITED STATES
View details

Uwe Völker

Professor, Head of Department

Universitätsmedizin Greifswald

GERMANY
View details

Masayuki Mizui

Osaka University Graduate School of Medicine

JAPAN
View details

Steven Reilly

Assistant Professor

Yale University

UNITED STATES
View details

Jan Veldink

Professor of Neurology and Neurogenetics

University Medical Center Utrecht, Utrecht University

NETHERLANDS
View details

Todd Edwards

Assistant Professor

Vanderbilt University

UNITED STATES
View details

Suvi Rovio

Adjunct professor, senor researcher

University of Turku

FINLAND
View details

Kit Curtius

Research Health Scientist (PI)

University of California, San Diego

UNITED STATES
View details

Carlos Cruchaga

Professor

Washington University in St. Louis

UNITED STATES
View details

Carla van der Kallen

University of Maastricht

NETHERLANDS
View details

Kazuma Sugie

-

JAPAN
View details

Terho Lehtimäki

University of Tampere

FINLAND
View details

Greg Gibson

Regents Professor

Georgia Tech

UNITED STATES
View details

Shinichi Takahashi

Professor

Keio University School of Medicine

JAPAN
View details

Melissa Bondy

Professor/Department Chair

Stanford University

UNITED STATES
View details

Marleen van Greevenbroek

University of Maastricht

NETHERLANDS
View details

Benjamin Langmead

Associate Professor

Johns Hopkins University

UNITED STATES
View details

Janusz Jankowski

Professor

University College London

UNITED KINGDOM
View details

Richard Gallo

University of California, San Diego

UNITED STATES
View details

WeiQi Wei

Professor

Vanderbilt University Medical Center

UNITED STATES
View details

Yun Li

Professor

University of North Carolina

UNITED STATES
View details

Satoru Morimoto

Project Professor

Keio University School of Medicine

JAPAN
View details

Ryuta Saito

Professor

Nagoya University Graduate School of Medicine

JAPAN
View details

Kazuya Motomura

Chief

Nagoya University Graduate School of Medicine

JAPAN
View details

Yuki Saito

National Cancer Center Research Institute

JAPAN
View details

Dorret I Boomsma

Full professor

University of Amsterdam

NETHERLANDS
View details

Takanori Hasegawa

Associate Professor

Institute of Science Tokyo

JAPAN
View details